entertainment -WSS

entertainment

author：leisure time 2025-10-02 13:14:03 - browse：2

Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Amylyx ALS drug failure raises questions and concerns

knowledge

WSS

See how much Covid

ASCO: AstraZeneca says CAR

Letters to First Opinion on caregivers, digital health, and more

Shifting the focus from loneliness to social health

Novo Nordisk obesity pill bests Wegovy in early trial

The Readout: Amylyx, Alumis, and Lundbeck drug updates

hotspot

entertainment

knowledge

Peter Hotez and the public health issue of online harassment

BMI, flaws aside, is found to be useful estimate of body fat in youth

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Cancer drug shortages should be causing more outrage

Ionis drug prevents swelling attacks due to hereditary angioedema

New air purifier tech could be key to improving indoor air quality

The problem with charging patients to message their doctors

Supreme Court strikes down use of affirmative action

Letters to First Opinion on caregivers, digital health, and more

entertainment

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Amylyx ALS drug failure raises questions and concerns

A deep dive into Applied Therapeutics’ data, and questions on Cassava

NEJM study link tiny plastics in blood vessels to heart problems

Air quality improving but still lags in Black, Hispanic communities

Letters to First Opinion on caregivers, digital health, and more

hotspot

knowledge

hotspot

focus